ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMDespesas comerciais, gerais e administrativas595.2 M546 M579.3 M552.4 M538.6 M551 M2.22 BPesquisa e desenvolvimento———————Lucro operacional216.5 M326 M394.5 M396.6 M267.6 M380.8 M1.44 BLucro não operacional, total31.2 M5.5 M-31 M1.6 M-16.1 M-900 K-46.4 MDespesa com juros, líquida de juros capitalizados63.4 M56 M57.1 M56 M55 M55.1 M223.2 MReceitas não operacionais, líquidas das despesas com juros-48.6 M-49.5 M-55.4 M-52.5 M-51.7 M-42.9 M-202.5 MReceitas/despesas incomuns16.4 M-1 M-32.7 M-1.9 M-19.4 M-13.1 M-67.1 MLucro antes dos impostos958.8 M2.73 B2.88 B2.94 B1.1 B2.91 B9.82 BParticipação no lucro-700 K-300 K-1.7 M-5.2 M-6.1 M-5.1 M-18.1 MImpostos40.2 M62.2 M66.4 M75.5 M25.7 M41.7 M209.3 MParticipação de minoritários200 K200 K400 K400 K200 K200 K1.2 MOutras receitas/despesas após impostos———————Lucro líquido antes das operações descontinuadas143.4 M212.8 M237.9 M261.1 M164.7 M277.8 M941.5 MOperações descontinuadas0———0——Lucro líquido143.4 M212.8 M237.9 M261.1 M164.7 M277.8 M941.5 MAjuste de diluição———————Dividendos de ações preferenciais———————Lucro líquido diluído disponível aos acionistas143.4 M212.8 M237.9 M261.1 M164.7 M277.8 M941.5 MLucro básico por ação1.722.542.853.142.013.3711.37Lucro diluído por ação1.722.522.843.121.983.3511.29Número médio de ações básicas83.9 M83.6 M83.4 M83.1 M83.2 M82.3 M—Ações diluídas84.4 M84.3 M83.9 M83.7 M83.8 M82.9 M—EBITDA214 M504.1 M568.9 M574.9 M340.8 M560.6 M2.05 BEBIT53.2 M327.5 M398.6 M403.9 M167.8 M387.3 M1.36 BCusto da receita2.43 B2.4 B2.48 B2.54 B2.52 B2.52 B10.07 BOutros componentes do custo———————Amortização e depreciação (fluxo de caixa)170.6 M166.8 M170.3 M171 M173 M173.3 M687.6 M
Labcorp Holdings Inc. Common Stock
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program.